Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent

Carcinogenesis

Volumn 32, Issue 9, 2011, Pages 1361-1365

  Taioli, Emanuela ^a   Flores Obando, Rafael E ^b   Agalliu, Ilir ^c   Blanchet, Pascal ^d   Bunker, Clareann H ^e   Ferrell, Robert E ^f   Jackson, Maria ^g   Kidd, La Creis R ^h,i   Kolb, Suzanne ^j   Lavender, Nicol A ⁱ   McFarlane Anderson, Norma ^g   Morrison, Seian S ^g   Multigner, Luc ^k   Ostrande, Elaine A ^l   Park, Jong Y ^m   Patrick, Alan L ⁿ   Rebbeck, Timothy R ^o   Romana, Marc ^p   Stanford, Janet L ^j   Ukoli, Flora ^q   VanCleave, Tiva T ^h   Zeigler Johnson, Charnita M ^m   Mutetwa, Batsirai ^b   Ragin, Camille ^r   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITÉ DE GUYANE   (France)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g UNIVERSITY OF THE WEST INDIES   (Jamaica)

^h University of Louisville School of Medicine   (United States)

ⁱ UNIVERSITY OF LOUISVILLE   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

^k Campus de Beaulieu   (France)

^l NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^m H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁿ Tobago Health Studies Office   (Trinidad and Tobago)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p Institut National de la Santé et de la Recherche Médicale U763   (France)

^q MEHARRY MEDICAL COLLEGE   (United States)

^r FOX CHASE CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AFRICAN AMERICAN; AFRICAN CARIBBEAN; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; SMOKING;

EID: 80052402549     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr119     Document Type: Article

References (43)

1. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Altekruse, S.F. (eds). et al. (2010) SEER Cancer Statistics Review, (1975-2007). National Cancer Institute, Bethesda, MD.
3. Bunker, C.H. et al. (2002) High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol. Biomarkers Prev., 11, 726-729.
4. Chokunonga, E. et al. (2000) Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int. J. Cancer, 85, 54-59.
5. Ravery, V. et al. (2008) Prostate cancer characteristics in a multiracial community. Eur. Urol., 53, 533-538.
6. Ben-Shlomo, Y. et al. (2008) The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur. Urol., 53, 99-105.
7. Mallick, S. et al. (2005) Prostate cancer incidence in Guadeloupe, a French Caribbean archipelago. Eur. Urol., 47, 769-772.
8. Detchokul, S. et al. (2011) Recent developments in prostate cancer biomarker research: therapeutic implications. Br. J. Clin. Pharmacol., 71, 157-174.
9. Croft, D. et al. (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res., 39, D691-D697.
10. Coughlin, S.S. et al. (2002) A review of genetic polymorphisms and prostate cancer risk. Ann. Epidemiol., 12, 182-196.
11. Sundberg, K. et al. (2002) Glutathione conjugation and DNA adduct formation of dibenzo[a, l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases. Chem. Res. Toxicol., 15, 170-179.
12. Hayes, J.D. et al. (2005) Glutathione transferases. Ann. Rev. Pharmacol. Toxicol., 45, 51-88.
13. Wilkinson, J.T. et al. (1997) Detoxication enzymes and chemoprevention. Proc. Soc. Exp. Biol. Med., 216, 192-200.
14. Ragin,C.C. et al. (2010) Review of studies on metabolic genes and cancer in populations of African descent. Genet. Med., 12, 12-18.
15. Kidd, L.C. et al. (2003) Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur. J. Cancer Prev., 12, 317-320.
16. Quinones, L.A. et al. (2006) Joint effect among p.53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J. Androl., 8, 349-355.
17. Mao, G.E. et al. (2004) Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect. Prev., 28, 368-374.
18. Ning, B. et al. (2004) Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics, 14, 35-44.
19. Beer, T.M. et al. (2002) Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer Prostatic Dis., 5, 22-27.
20. Debes, J.D. et al. (2004) Gluthatione-S-transferase P1 polymorphismI105Vin familial and sporadic prostate cancer. Cancer Genet. Cytogenet., 155, 82-86.
21. Nock, N.L. et al. (2007) Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol. Biomarkers Prev., 16, 1236-1245.
22. Rybicki, B.A. et al. (2006) Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect. Prev., 30, 412-422.
23. Agalliu, I. et al. (2006) Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate, 66, 1535-1541.
24. Woodson, K. et al. (2004) A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett., 205, 181-188.
25. Woodson, K. et al. (2003) Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks andWhites. Prostate, 55, 199-205.
26. Garte, S. (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev., 10, 1239-1248.
27. Cunningham, J.M. et al. (2007) Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol. Biomarkers Prev., 16, 969-978.
28. Mallick, S. et al. (2007) GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent. Urology, 69, 1165-1169.
29. Agalliu, I. et al. (2006) Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate, 66, 146-156.
30. Kelada, S.N. et al. (2000) The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol. Biomarkers Prev., 9, 1329-1334.
31. Rebbeck, T.R. et al. (1999) Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol. Biomarkers Prev., 8, 283-287.
32. Lavender, N.A. et al. (2009) Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer, 9, 397.
33. Ragin, C.C. et al. (2007) African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors. Infect. Agent Cancer, 2, 17.
34. Taioli, E. (1999) International collaborative study on genetic susceptibility to environmental carcinogens. Cancer Epidemiol. Biomarkers Prev., 8, 727-728.
35. Sutton, A.J. et al. (2004) Methods for Meta-Analysis in Medical Research. John Wiley and Sons Ltd, Chichester, UK.
36. Higgins, J.P. et al. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.
37. Ioannidis, J.P. et al. (2007) Uncertainty in heterogeneity estimates in metaanalyses. BMJ, 335, 914-916.
38. Egger, M. et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
39. Ntais, C. et al. (2005) Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 14, 176-181.
40. Mo, Z. et al. (2009) An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate, 69, 662-688.
41. Taylor, M.L. et al. (2005) Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam. Med., 37, 506-512.
42. Norskov, M.S. et al. (2010) Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population. Pharmacogenomics J., Jun 1. PMID: 2051407.
43. Multigner, L. et al. (2010) Chlordecone exposure and risk of prostate cancer. J. Clin. Oncol., 28, 3457-3462.